Annual Review of Cancer Biology

Papers
(The TQCC of Annual Review of Cancer Biology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond62
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo45
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer26
Immune Cell Metabolism and Immuno-Oncology24
Targeting Solid Tumors with Bispecific T Cell Engager Immune Therapy23
Allogeneic CAR T Cell Therapy for Cancer22
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?20
Caught in a Web: Emerging Roles of Neutrophil Extracellular Traps in Cancer19
Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division19
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies18
Cancer Dependency Map: Past and Present16
Road Map to Defeat Pancreatic Cancer16
Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches13
Rationales for Combining Therapies to Treat Cancer: Independent Action, Response Correlation, and Collateral Sensitivity Versus Synergy13
An Erratic Path Toward Discovery13
The Effects of Clonal Heterogeneity on Cancer Immunosurveillance12
Strategies for Heating Up Cold Tumors to Boost Immunotherapies11
Reinventing Radiobiology in the Light of FLASH Radiotherapy11
Extrachromosomal DNA: Biogenesis and Functions in Cancer10
Engineering the Immune Microenvironment into Organoid Models10
RB1, Cancer Lineage Plasticity, and Therapeutic Resistance10
0.026093006134033